{
  "actions": [
    {
      "acted_at": "2002-05-08", 
      "references": [
        {
          "reference": "CR S4077", 
          "type": null
        }
      ], 
      "text": "Sponsor introductory remarks on measure.", 
      "type": "action"
    }, 
    {
      "acted_at": "2002-05-08", 
      "committee": "Committee on Finance", 
      "references": [
        {
          "reference": "CR S4077-4078", 
          "type": "text of measure as introduced"
        }
      ], 
      "status": "REFERRED", 
      "text": "Read twice and referred to the Committee on Finance.", 
      "type": "referral"
    }, 
    {
      "acted_at": "2002-07-18", 
      "references": [
        {
          "reference": "CR S6968-6969", 
          "type": null
        }
      ], 
      "text": "Sponsor introductory remarks on measure.", 
      "type": "action"
    }
  ], 
  "amendments": [], 
  "bill_id": "s2486-107", 
  "bill_type": "s", 
  "committees": [
    {
      "activity": [
        "referral", 
        "in committee"
      ], 
      "committee": "Senate Finance", 
      "committee_id": "SSFI"
    }
  ], 
  "congress": "107", 
  "cosponsors": [
    {
      "district": null, 
      "name": "Carnahan, Jean", 
      "sponsored_at": "2002-05-08", 
      "state": "MO", 
      "thomas_id": "01680", 
      "title": "Sen", 
      "withdrawn_at": null
    }, 
    {
      "district": null, 
      "name": "Daschle, Thomas A.", 
      "sponsored_at": "2002-05-08", 
      "state": "SD", 
      "thomas_id": "00267", 
      "title": "Sen", 
      "withdrawn_at": null
    }, 
    {
      "district": null, 
      "name": "Durbin, Richard", 
      "sponsored_at": "2002-05-08", 
      "state": "IL", 
      "thomas_id": "00326", 
      "title": "Sen", 
      "withdrawn_at": null
    }, 
    {
      "district": null, 
      "name": "Miller, Zell", 
      "sponsored_at": "2002-05-08", 
      "state": "GA", 
      "thomas_id": "01624", 
      "title": "Sen", 
      "withdrawn_at": null
    }, 
    {
      "district": null, 
      "name": "Wellstone, Paul D.", 
      "sponsored_at": "2002-05-08", 
      "state": "MN", 
      "thomas_id": "01454", 
      "title": "Sen", 
      "withdrawn_at": null
    }
  ], 
  "enacted_as": null, 
  "history": {
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2002-05-08", 
  "number": "2486", 
  "official_title": "A bill to amend the Internal Revenue Code of 1986 to limit the deduction for advertising of FDA approved prescription drugs by the manufacturer of such drugs to the level of such manufacturer's research and development expenditures, and for other purposes.", 
  "popular_title": null, 
  "related_bills": [
    {
      "bill_id": "hr4821-107", 
      "reason": "identical"
    }
  ], 
  "short_title": "Fair Advertising and Increased Research (FAIR) Act", 
  "sponsor": {
    "district": null, 
    "name": "Stabenow, Debbie", 
    "state": "MI", 
    "thomas_id": "01531", 
    "title": "Sen", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2002-05-08", 
  "subjects": [
    "Advertising", 
    "Appropriations", 
    "Business income tax", 
    "Commerce", 
    "Drug industry", 
    "Economics and public finance", 
    "Government operations and politics", 
    "Government trust funds", 
    "Health", 
    "Income tax", 
    "Marketing", 
    "Medicare", 
    "Pharmaceutical research", 
    "Research and development", 
    "Sales promotion", 
    "Science, technology, communications", 
    "Social welfare", 
    "Tax deductions", 
    "Taxation"
  ], 
  "subjects_top_term": "Taxation", 
  "summary": {
    "as": "Introduced", 
    "date": "2002-05-08", 
    "text": "Fair Advertising and Increased Research Act - Amends the Internal Revenue Code to prohibit any drug manufacturer from taking a tax deduction for expenditures relating to the advertising, promoting, or marketing of any FDA prescription drug to the extent the aggregate amount of such expenditures exceeds the manufacturer's aggregate research and development expenditures.Directs the Secretary of the Treasury to estimate amount of additional tax revenues raised by enforcement of the Act, to be allocated to the Federal Hospital Insurance Trust Fund."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "title": "Fair Advertising and Increased Research (FAIR) Act", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "title": "A bill to amend the Internal Revenue Code of 1986 to limit the deduction for advertising of FDA approved prescription drugs by the manufacturer of such drugs to the level of such manufacturer's research and development expenditures, and for other purposes.", 
      "type": "official"
    }
  ], 
  "updated_at": "2013-02-02T20:47:32-05:00"
}